AstraZeneca competitorsClear all
Boehringer Ingelheim's top competitors include Sanofi, Amgen, Bayer and Teva Pharmaceuticals.
 Boehringer Ingelheim Boehringer Ingelheim International is a global pharmaceutical company engaged in human pharmaceuticals, animal health, and biopharmaceuticals businesses. |  Sanofi Sanofi is a global healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions. |  Amgen Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products. | |||
Founding Date | Founding Date 1885 | Founding Date 2004 | Founding Date 1980 | Founding Date 1863 | Founding Date 1901 |
Type | Type Subsidiary | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Ingelheim am Rhein, DE HQ Algiers, DZ Munro, AR Macquarie Park, AU Vienna, AT Minsk, BY Elsene, BE see more | Locations Thousand Oaks, US HQ Hydra, DZ Vicente López, AR Sydney, AU Wien, AT Machelen, BE Santo Amaro, BR see more | Locations Petah Tikva, IL HQ Villa Adelina, AR Macquarie Park, AU Minsk, BY Antwerpen, BE São Paulo, BR Dupnica, BG see more | ||
Employees | Employees 52,3911% increase | Employees 95,4424% decrease | Employees 24,200 | Employees 99,6372% decrease | Employees 37,100 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 132.1 b | Valuation ($) 137.4 b | Valuation ($) 65.3 b | Valuation ($) N/A |
Twitter followers | Twitter followers 104.6 k | Twitter followers 147.8 k | Twitter followers 105.3 k | Twitter followers 183 k | Twitter followers 3.6 k |
Number of tweets (last 30 days) | Number of tweets (last 30 days) 25 | Number of tweets (last 30 days) 15 | Number of tweets (last 30 days) 136 | Number of tweets (last 30 days) 66 | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) 6.4 | Average likes per tweet (last 30 days) 17.7 | Average likes per tweet (last 30 days) 5.9 | Average likes per tweet (last 30 days) 19.1 | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 95.59% | Percentage of tweets with engagement (last 30 days) 62.12% | Percentage of tweets with engagement (last 30 days) N/A |
Alexa Website Rank | Alexa Website Rank 176211 | Alexa Website Rank 178741 | Alexa Website Rank 181163 | Alexa Website Rank 77182 | Alexa Website Rank 338084 |
Employee Rating | Employee Rating 4.1 | Employee Rating N/A | Employee Rating 4.1 | Employee Rating 4.3 | Employee Rating 3.6 |
Financial | |||||
Revenue (est.) | Revenue (est.) €21.3b (FY, 2019) | Revenue (est.) €37.8b (FY, 2021) | Revenue (est.) $26b (FY, 2021) | Revenue (est.) €44.1b (FY, 2021) | Revenue (est.) $16.7b (FY, 2020) |
Cost of goods | Cost of goods €7.3b (FY, 2019) | Cost of goods (€10.7b) (FY, 2021) | Cost of goods $6.5b (FY, 2021) | Cost of goods (€11.7b) (FY, 2021) | Cost of goods $8.9b (FY, 2020) |
Gross profit | Gross profit €14b (FY, 2019) | Gross profit €28.9b (FY, 2021) | Gross profit N/A | Gross profit €33.6b (FY, 2021) | Gross profit $7.7b (FY, 2020) |
Net income | Net income €2.7b (FY, 2019) | Net income €6.2b (FY, 2021) | Net income $5.9b (FY, 2021) | Net income €1b (FY, 2021) | Net income ($4.1b) (FY, 2020) |
Operating ⚠ | |||||
Countries | Countries N/A | Countries N/A | Countries 100 (FY, 2020) | Countries 153 (FY, 2018) | Countries N/A |
Facilities | Facilities N/A | Facilities N/A | Facilities 180 (FY, 2020) | Facilities N/A | Facilities 90 (FY, 2019) |
Phase II Trials Products | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products 5 (FY, 2020) | Phase II Trials Products 12 (Jan, 2020) | Phase II Trials Products N/A |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products 11 (FY, 2020) | Phase III Trials Products 9 (Jan, 2020) | Phase III Trials Products N/A |
Suppliers | Suppliers N/A | Suppliers 68 k (FY, 2019) | Suppliers N/A | Suppliers 86.4 k (FY, 2019) | Suppliers N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 310m | Total funding raised N/A | Total funding raised $ 3.5b | Total funding raised $ 358m |
For sources of this data, please see the company profile
View company profiles
Sanofi
HQ
Paris, FR
Employees
95,442↓ 4% decrease
Sanofi is a global healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions.
View companyAmgen
HQ
Thousand Oaks, US
Employees
24,200
Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products.
View company
Bayer
HQ
Leverkusen, DE
Employees
99,637↓ 2% decrease
Bayer is a global life science company specializing in healthcare and nutrition.
View company
Teva Pharmaceuticals
HQ
Petah Tikva, IL
Employees
37,100
Teva Pharmaceuticals is a global pharmaceutical company.
View company